Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Singapore eDevelopment Limited
Singapore eDevelopment Limited
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Ingredients
Impact Biomedical initiates research programme to solve the patent cliff
The primary cause of the patent crisis is that most techniques for modifying natural molecules to pharmaceutical grade products are essentially 'played out'
Research & Development
Equivir shows prophylactic COVID-19 results in independent testing
Impact Biomedical has announced in vitro success with Equivir and 3F Biofragrance against COVID-19 in independent laboratory testing
Ingredients
Impact BioMedical looks at compounds that block coronavirus mechanisms
The coronavirus has presented a unique challenge to exploit a 'hand shake' docking site to human cellular membranes that is atypical of Influenza and Rhinovirus
Research & Development
Singapore eDevelopment researches universal drug platform
Six month target for validating lab data, twelve month target for completion of platform
Subscribe now